Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study by Junting Huang, Jia Zhu, Lian Jiang, Jiaqian Xu, Xiheng Lin, Jian Chang, Xiaohong Zhang, Suying Lu, Feifei Sun, Juan Wang, Yi Que, Zhonglv Ye, Lihua Yang, Xiuli Yuan, Weisong Cai, Chuan Tian, Yanpeng Wu, Xiangling He, Yan-Lai Tang, Yizhuo Zhang

Connect to this object online.